Drug profile · INN
casopitant
ZUNRISA
casopitant (ZUNRISA) is a neurokinin 1 receptor antagonist.
EMA: application withdrawn
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — casopitant
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
casopitant (ZUNRISA) is a neurokinin 1 receptor antagonist.
Key facts
INN casopitant
Brand ZUNRISA
Mechanism Neurokinin 1 receptor antagonist
Target Substance-P receptor
Mechanism of action
Neurokinin 1 receptor antagonist
Primary target: Substance-P receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is casopitant?
casopitant (ZUNRISA) is a neurokinin 1 receptor antagonist.
What is the brand name for casopitant?
ZUNRISA is a marketed brand name for casopitant. Check FDA Drugs@FDA for the current US label holder and prescribing information.